| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | MEDTRONIC PLC | 7,800 | 677,000 | 0.01% | ||
| 102 | ACADIA PHARMACEUTICALS INC COM | 20,390 | 662,000 | 0.01% | ||
| 103 | KEMPHARM INC | 165,000 | 657,000 | 0.01% | ||
| 104 | VANTIV INC | 11,400 | 645,000 | 0.01% | ||
| 105 | Oxford Immunotec Global PLC | 70,460 | 634,000 | 0.01% | ||
| 106 | LILLY ELI & CO | 7,100 | 560,000 | 0.01% | ||
| 107 | ACCELERON PHARMA INC | 16,400 | 557,000 | 0.01% | ||
| 108 | INTERCEPT PHARMACEUTICALS INCORPORATED | 3,800 | 542,000 | 0.01% | ||
| 109 | PTC THERAPEUTICS INC | 63,700 | 447,000 | 0.01% | ||
| 110 | BLUEBIRD BIO INC COM | 6,400 | 277,000 | 0.01% | ||
| 111 | ACORDA THERAPEUTICS INC | 10,000 | 255,000 | 0.00% | ||
| 112 | CREDICORP LTD | 1,400 | 216,000 | 0.00% | ||
| 113 | Esperion Therapeutics Inc | 19,000 | 188,000 | 0.00% | ||
| 114 | TRANSENTERIX INC | 150,000 | 180,000 | 0.00% | ||
| 115 | NEWLINK GENETICS CORP COM | 13,235 | 149,000 | 0.00% | ||
| 116 | ADVANCED SEMICONDUCTOR ENGR SPONSORED ADR | 25,300 | 141,000 | 0.00% | ||
| 117 | INFINITY PHARMACEUTICALS INC | 40,680 | 54,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001625244-16-000010, filed 2016.07.29).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
